EuPCV15
/ EuBiologics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 07, 2021
Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults
(clinicaltrials.gov)
- P1; N=60; Completed; Sponsor: EuBiologics Co.,Ltd; Active, not recruiting ➔ Completed; Trial completion date: Jun 2021 ➔ Feb 2021
Clinical • Trial completion • Trial completion date • Infectious Disease • Pneumococcal Infections
April 05, 2021
Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults
(clinicaltrials.gov)
- P1; N=60; Active, not recruiting; Sponsor: EuBiologics Co.,Ltd
New P1 trial • Infectious Disease
1 to 2
Of
2
Go to page
1